THERAPEUTIC TARGETING OF NOX2 TO TARGET BONE METASTATIC PROSTATE CANCER PROGRESSION AND IMMUNE EVASION

$926,248FY2021Defense Health AgencyDOD

The Geneva Foundation

Investigators